X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (399) 399
Book Review (44) 44
Publication (39) 39
Conference Proceeding (10) 10
Book Chapter (4) 4
Book / eBook (2) 2
Patent (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (249) 249
humans (245) 245
oncology (165) 165
male (140) 140
radiotherapy (123) 123
radiology, nuclear medicine & medical imaging (111) 111
middle aged (103) 103
aged (95) 95
female (88) 88
cancer (68) 68
radiotherapy dosage (55) 55
hematology, oncology and palliative medicine (54) 54
adult (52) 52
lung neoplasms - radiotherapy (52) 52
prostatic neoplasms - radiotherapy (50) 50
aged, 80 and over (49) 49
radiation-therapy (46) 46
care and treatment (45) 45
radiology (45) 45
treatment outcome (45) 45
chemotherapy (40) 40
quality of life (40) 40
lung neoplasms - pathology (38) 38
radiation (38) 38
carcinoma, non-small-cell lung - radiotherapy (36) 36
combined modality therapy (36) 36
radiology and nuclear medicine (35) 35
neoplasm staging (33) 33
prostate cancer (32) 32
surgery (32) 32
patients (31) 31
therapy (31) 31
carcinoma, non-small-cell lung - pathology (30) 30
lung neoplasms - drug therapy (29) 29
article (28) 28
irradiation (28) 28
quality-of-life (27) 27
radiation therapy (27) 27
survival (27) 27
dose fractionation (26) 26
follow-up studies (26) 26
lung cancer (26) 26
radiotherapy planning, computer-assisted - methods (26) 26
survival analysis (26) 26
retrospective studies (25) 25
analysis (24) 24
carcinoma (24) 24
carcinoma, non-small-cell lung - drug therapy (24) 24
research (24) 24
cell lung-cancer (23) 23
prostatic neoplasms - pathology (23) 23
clinical trials (22) 22
lung neoplasms - therapy (22) 22
lung cancer, non-small cell (21) 21
respiratory system (21) 21
algorithms (20) 20
neoplasms (20) 20
tumors (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
radiosurgery (19) 19
united states (19) 19
prospective studies (18) 18
carcinoma, non-small-cell lung - therapy (17) 17
multivariate analysis (17) 17
neoplasms - radiotherapy (17) 17
prognosis (17) 17
toxicity (17) 17
abridged index medicus (16) 16
brachytherapy (16) 16
lungs (16) 16
nuclear radiation (16) 16
randomized controlled trials as topic (16) 16
surveys and questionnaires (16) 16
head (15) 15
phantoms, imaging (15) 15
phase-iii trial (15) 15
prostate (15) 15
prostate-specific antigen - blood (15) 15
radiation injuries - prevention & control (15) 15
radiosurgery - methods (15) 15
randomized-trial (15) 15
medicine & public health (14) 14
time factors (14) 14
tomography, x-ray computed - methods (14) 14
brain neoplasms - radiotherapy (13) 13
carcinomas (13) 13
clinical trials as topic (13) 13
computed tomography (13) 13
cone-beam computed tomography (13) 13
disease-free survival (13) 13
neck-cancer (13) 13
proportional hazards models (13) 13
prostatic neoplasms - diagnostic imaging (13) 13
radiation doses (13) 13
radiation oncology (13) 13
radiotherapy planning, computer-assisted (13) 13
risk factors (13) 13
survival rate (13) 13
chemoradiotherapy (12) 12
computerized tomography (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 10/2011, Volume 103, Issue 19, pp. 1452 - 1460
Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared with TRT alone has been shown to confer a survival advantage for good... 
IRRADIATION | CARBOPLATIN | CISPLATIN | VINORELBINE | ONCOLOGY | THERAPY-ONCOLOGY-GROUP | CHEMORADIOTHERAPY | RADIOTHERAPY | CHEMOTHERAPY | RADIATION-THERAPY | PACLITAXEL | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | United States | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Time Factors | Vinblastine - adverse effects | Aged, 80 and over | Adult | Dose Fractionation | Chemotherapy, Adjuvant | Odds Ratio | Radiotherapy, Adjuvant | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Etoposide - adverse effects | Drug Administration Schedule | Kaplan-Meier Estimate | Etoposide - administration & dosage | Treatment Outcome | Disease Progression | Canada | Confounding Factors (Epidemiology) | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Etoposide | Research | Lung cancer, Non-small cell | Drug therapy | Radiotherapy | Health aspects | Survival analysis | Oncology | Chemotherapy | Lung cancer | Clinical outcomes | Index Medicus
Journal Article
2001, Basic and clinical oncology, ISBN 0824702743, Volume 25., 535
Book
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 425 - 434
Purpose Patients treated with chemoradiotherapy for locally advanced non–small-cell lung carcinoma (LA-NSCLC) were analyzed for local-regional failure (LRF)... 
Radiology | Hematology, Oncology and Palliative Medicine | Survival with respect to radiotherapy dose intensity | Local-regional failure | Radiation oncology | Chemoradiotherapy | Advanced non–small-cell lung carcinoma | Advanced non-small-cell lung carcinoma | LEUKEMIA GROUP-B | INDUCTION CHEMOTHERAPY | CONSOLIDATION DOCETAXEL | COMPETING RISK | FOLLOW-UP | CANCER | PHASE-III TRIAL | ONCOLOGY | HYPERFRACTIONATED RADIATION | CONCURRENT CHEMORADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | THORACIC RADIOTHERAPY | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Treatment Failure | Aged, 80 and over | Adult | Female | Retrospective Studies | Paclitaxel - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Chemoradiotherapy - methods | Proportional Hazards Models | Carboplatin - administration & dosage | Etoposide - administration & dosage | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Amifostine - administration & dosage | Aged | Relative Biological Effectiveness | Medical colleges | Care and treatment | Carcinoma | Nuclear radiation | Patient outcomes | Lung cancer, Non-small cell | Radiotherapy | Cancer | Statistical analysis | Lung | Radiation | Clinical trials | Non-small cell lung carcinoma | Data processing | Dose-response effects | Oncology | Radiation therapy | Multivariate analysis | Survival | Index Medicus | MULTIVARIATE ANALYSIS | PATIENTS | TESTING | FAILURES | LUNGS | CARCINOMAS | STANDARDS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | RADIOTHERAPY | COMBINED THERAPY | HAZARDS | chemoradiotherapy | local-regional failure | Radiation Oncology | advanced non-small-cell lung carcinoma | survival with respect to radiotherapy dose intensity
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 77 - 84
Purpose To determine the effect of dose and fractionation schedule of prophylactic cranial irradiation (PCI) on the incidence of chronic neurotoxicity (CNt)... 
Radiology | Hematology, Oncology and Palliative Medicine | Limited-disease small-cell lung cancer | Prophylactic cranial irradiation | Neuropsychological testing | Chronic neurotoxicity | Quality of life | LONG-TERM SURVIVORS | TEST-RETEST | COMPLETE REMISSION | COMPLETE RESPONSE | FOLLOW-UP | CHEMOTHERAPY | ONCOLOGY | CLINICAL-TRIALS | EUROPEAN-ORGANIZATION | QUESTIONNAIRE | PSYCHOMETRIC VALIDATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lung Neoplasms - drug therapy | Follow-Up Studies | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Brain - radiation effects | Cranial Irradiation | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - secondary | Brain Neoplasms - prevention & control | Neuropsychological Tests | Small Cell Lung Carcinoma - prevention & control | Regression Analysis | Small Cell Lung Carcinoma - radiotherapy | Aged, 80 and over | Quality of Life | Adult | Dose Fractionation | Female | Aged | Chronic Disease | Care and treatment | Cancer patients | Analysis | Lung cancer | Radiation | Clinical trials | Radiotherapy | Index Medicus | NEOPLASMS | STATISTICS | LUNGS | RADIATION DOSES | STANDARD OF LIVING | MEDICINE | NUCLEAR MEDICINE | MATHEMATICS | IRRADIATION | ORGANS | DISEASES | THERAPY | DOSES | RESPIRATORY SYSTEM | RADIOLOGY AND NUCLEAR MEDICINE | REGRESSION ANALYSIS | RADIOTHERAPY | BODY | RADIOLOGY | HAZARDS | SCHEDULES | neuropsychological testing | prophylactic cranial irradiation | Limited disease small cell lung cancer | chronic neurotoxicity | quality of life
Journal Article
Journal Article
2002, ISBN 0721687385, xiv, 221 p., [14] p. of plates
Book
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 5, pp. 1442 - 1457
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 4, pp. 656 - 664
Journal Article
Journal Article